Photo taken from Toni Choueiri/LinkedIn
Jan 30, 2024, 16:28
Toni Choueiri: OS benefit in adjuvant Renal Cancer is finally here
Toni Choueiri, Medical Doctor and Professor at Dana-Farber Cancer Institute, recently posted on LinkedIn:
“51 years in the making till GU24. OS benefit in adjuvant Renal Cancer is finally here.
Lucky to be part of this journey. Gratitude to patients and families that go on trials. Thank you!”
Source: Toni Choueiri/LinkedIn
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 4, 2025, 03:12
Sep 4, 2025, 03:01
Sep 4, 2025, 00:02
Sep 3, 2025, 22:35
Sep 3, 2025, 22:09
Sep 3, 2025, 20:48